Pharma Journalist -

Cambrex Corporation announced that it had completed the construction of a $24 million highly potent API (HPAPI) manufacturing facility at its site in Charles City, IA. The 6,000 sq. ft.…
Read More...

Pharmaceutical and biotechnology major Wockhardt has received approval from the United States Food & Drug Administration (US FDA) for an ANDA for 50mg injection of Decitabine, which…
Read More...

I-Mab Biopharma, a clinical stage biopharmaceutical company exclusively focused on the development of potential first-in-class and best-in-class biologics in immuno-oncology and…
Read More...

LEO Pharma A/S announced an expansion of the two companies' partnership agreement (signed in 2017) to further include antibodies from LEO Pharma's pipeline with the aim of achieving…
Read More...

The Vifor Pharma Group and Akebia Therapeutics announced that the companies have amended the terms of their licence agreement to sell vadadustat to Fresenius Medical Care North America…
Read More...

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and…
Read More...

Amgen and UCB announced that the U.S. Food and Drug Administration (FDA) has approved EVENITY (romosozumab-aqqg) for the treatment of osteoporosis in postmenopausal women at high risk…
Read More...

Concerto HealthAI announced that they have entered into a collaboration with Pfizer to advance work in Precision Oncology using Concerto HealthAI’s eurekaHealthTM platform, artificial…
Read More...

Examining the evolving technological and commercial landscape to enhance your precision medicine development Come join us in September 2019 and; thoroughly understand the latest…
Read More...

SMi reports: Metys Pharmaceuticals, Ensysce Biosciences & AstraZeneca will be speaking and presenting at the 19th Annual Pain Therapeutics conference in London, this May. Pain…
Read More...